Guanosine protects C6 astroglial cells against azide-induced oxidative damage: a putative role of heme oxygenase 1

2014 ◽  
Vol 130 (1) ◽  
pp. 61-74 ◽  
Author(s):  
André Quincozes-Santos ◽  
Larissa Daniele Bobermin ◽  
Débora Guerini Souza ◽  
Bruna Bellaver ◽  
Carlos-Alberto Gonçalves ◽  
...  
2005 ◽  
Vol 2 (2) ◽  
pp. 141-148 ◽  
Author(s):  
Rosaria Acquaviva ◽  
Agata Campisi ◽  
Giuseppina Raciti ◽  
Roberto Avola ◽  
Maria Barcellona ◽  
...  

2017 ◽  
Vol 428 (1-2) ◽  
pp. 67-77 ◽  
Author(s):  
Bernardo Assein Arús ◽  
Débora Guerini Souza ◽  
Bruna Bellaver ◽  
Diogo Onofre Souza ◽  
Carlos-Alberto Gonçalves ◽  
...  

2012 ◽  
Vol 26 (1) ◽  
pp. 74-80 ◽  
Author(s):  
Shuang Liu ◽  
Wei Hou ◽  
Ping Yao ◽  
Na Li ◽  
Biyun Zhang ◽  
...  

2015 ◽  
Vol 29 (7) ◽  
pp. 1350-1357 ◽  
Author(s):  
Camila Leite Santos ◽  
Larissa Daniele Bobermin ◽  
Débora Guerini Souza ◽  
Bruna Bellaver ◽  
Gabriela Bellaver ◽  
...  

2018 ◽  
Vol 24 (20) ◽  
pp. 2283-2302 ◽  
Author(s):  
Vivian B. Neis ◽  
Priscila B. Rosa ◽  
Morgana Moretti ◽  
Ana Lucia S. Rodrigues

Heme oxygenase (HO) family catalyzes the conversion of heme into free iron, carbon monoxide and biliverdin. It possesses two well-characterized isoforms: HO-1 and HO-2. Under brain physiological conditions, the expression of HO-2 is constitutive, abundant and ubiquitous, whereas HO-1 mRNA and protein are restricted to small populations of neurons and neuroglia. HO-1 is an inducible enzyme that has been shown to participate as an essential defensive mechanism for neurons exposed to oxidant challenges, being related to antioxidant defenses in certain neuropathological conditions. Considering that neurodegenerative diseases (Alzheimer’s Disease (AD), Parkinson’s Disease (PD) and Multiple Sclerosis (MS)) and neuropsychiatric disorders (depression, anxiety, Bipolar Disorder (BD) and schizophrenia) are associated with increased inflammatory markers, impaired redox homeostasis and oxidative stress, conditions that may be associated with alterations in HO-levels/activity, the purpose of this review is to present evidence on the possible role of HO-1 in these Central Nervous System (CNS) diseases. In addition, the possible therapeutic potential of targeting brain HO-1 is explored in this review.


2017 ◽  
Vol 18 (6) ◽  
pp. 674-686 ◽  
Author(s):  
Aleksandra Piechota-Polanczyk ◽  
Alicja Jozkowicz

2004 ◽  
Vol 85 (1) ◽  
pp. 34-44 ◽  
Author(s):  
Isabel Devesa ◽  
Maria Luisa Ferrándiz ◽  
Isabel Guillén ◽  
José Miguel Cerdá ◽  
Maria José Alcaraz

Sign in / Sign up

Export Citation Format

Share Document